vs

Side-by-side financial comparison of Madison Square Garden Sports Corp. (MSGS) and Real Brokerage Inc (REAX). Click either name above to swap in a different company.

Real Brokerage Inc is the larger business by last-quarter revenue ($568.5M vs $403.4M, roughly 1.4× Madison Square Garden Sports Corp.). Madison Square Garden Sports Corp. runs the higher net margin — 2.0% vs -0.1%, a 2.1% gap on every dollar of revenue. On growth, Real Brokerage Inc posted the faster year-over-year revenue change (52.6% vs 12.8%). Madison Square Garden Sports Corp. produced more free cash flow last quarter ($31.6M vs $8.4M).

Madison Square Garden Sports Corp. is an American sports holding company based in New York City.

Anywhere Real Estate Inc., formerly Realogy, was an American real estate services firm. It operated and franchised real estate brands that provided brokerage, relocation, title, insurance, and settlement services. Brands included Better Homes and Gardens Real Estate, Century 21 Real Estate, Coldwell Banker, Corcoran Group, ERA Real Estate and Sotheby's International Realty. In 2026, the company was acquired by Compass, Inc.

MSGS vs REAX — Head-to-Head

Bigger by revenue
REAX
REAX
1.4× larger
REAX
$568.5M
$403.4M
MSGS
Growing faster (revenue YoY)
REAX
REAX
+39.9% gap
REAX
52.6%
12.8%
MSGS
Higher net margin
MSGS
MSGS
2.1% more per $
MSGS
2.0%
-0.1%
REAX
More free cash flow
MSGS
MSGS
$23.2M more FCF
MSGS
$31.6M
$8.4M
REAX

Income Statement — Q2 FY2026 vs Q3 FY2025

Metric
MSGS
MSGS
REAX
REAX
Revenue
$403.4M
$568.5M
Net Profit
$8.2M
$-447.0K
Gross Margin
7.9%
Operating Margin
5.5%
-0.1%
Net Margin
2.0%
-0.1%
Revenue YoY
12.8%
52.6%
Net Profit YoY
641.9%
82.7%
EPS (diluted)
$0.34
$0.00

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
MSGS
MSGS
REAX
REAX
Q4 25
$403.4M
Q3 25
$39.5M
$568.5M
Q2 25
$204.0M
$540.7M
Q1 25
$424.2M
$354.0M
Q4 24
$357.8M
Q3 24
$53.3M
$372.5M
Q2 24
$227.3M
Q1 24
$430.0M
$200.7M
Net Profit
MSGS
MSGS
REAX
REAX
Q4 25
$8.2M
Q3 25
$-8.8M
$-447.0K
Q2 25
$-1.8M
$1.5M
Q1 25
$-14.2M
$-5.0M
Q4 24
$1.1M
Q3 24
$-7.5M
$-2.6M
Q2 24
$25.5M
Q1 24
$37.9M
$-16.1M
Gross Margin
MSGS
MSGS
REAX
REAX
Q4 25
Q3 25
7.9%
Q2 25
8.9%
Q1 25
9.6%
Q4 24
Q3 24
8.6%
Q2 24
Q1 24
10.3%
Operating Margin
MSGS
MSGS
REAX
REAX
Q4 25
5.5%
Q3 25
-69.5%
-0.1%
Q2 25
-11.1%
0.3%
Q1 25
7.6%
-1.5%
Q4 24
3.7%
Q3 24
-15.5%
-0.7%
Q2 24
23.0%
Q1 24
18.5%
-7.8%
Net Margin
MSGS
MSGS
REAX
REAX
Q4 25
2.0%
Q3 25
-22.3%
-0.1%
Q2 25
-0.9%
0.3%
Q1 25
-3.4%
-1.4%
Q4 24
0.3%
Q3 24
-14.1%
-0.7%
Q2 24
11.2%
Q1 24
8.8%
-8.0%
EPS (diluted)
MSGS
MSGS
REAX
REAX
Q4 25
$0.34
Q3 25
$-0.37
$0.00
Q2 25
$-0.08
$0.01
Q1 25
$-0.59
$-0.02
Q4 24
$0.05
Q3 24
$-0.31
$-0.01
Q2 24
$1.07
Q1 24
$1.57
$-0.09

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
MSGS
MSGS
REAX
REAX
Cash + ST InvestmentsLiquidity on hand
$81.3M
$38.7M
Total DebtLower is stronger
Stockholders' EquityBook value
$-282.1M
$53.6M
Total Assets
$1.5B
$145.2M
Debt / EquityLower = less leverage

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
MSGS
MSGS
REAX
REAX
Q4 25
$81.3M
Q3 25
$48.6M
$38.7M
Q2 25
$144.6M
$49.7M
Q1 25
$96.5M
$24.7M
Q4 24
$107.8M
Q3 24
$52.3M
$22.6M
Q2 24
$89.1M
Q1 24
$40.0M
$20.1M
Stockholders' Equity
MSGS
MSGS
REAX
REAX
Q4 25
$-282.1M
Q3 25
$-294.2M
$53.6M
Q2 25
$-281.4M
$49.2M
Q1 25
$-283.4M
$32.8M
Q4 24
$-273.1M
Q3 24
$-277.5M
$29.8M
Q2 24
$-266.3M
Q1 24
$-294.0M
$25.6M
Total Assets
MSGS
MSGS
REAX
REAX
Q4 25
$1.5B
Q3 25
$1.5B
$145.2M
Q2 25
$1.5B
$149.4M
Q1 25
$1.5B
$100.5M
Q4 24
$1.4B
Q3 24
$1.4B
$102.5M
Q2 24
$1.3B
Q1 24
$1.4B

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
MSGS
MSGS
REAX
REAX
Operating Cash FlowLast quarter
$32.4M
$8.8M
Free Cash FlowOCF − Capex
$31.6M
$8.4M
FCF MarginFCF / Revenue
7.8%
1.5%
Capex IntensityCapex / Revenue
0.2%
0.1%
Cash ConversionOCF / Net Profit
3.94×
TTM Free Cash FlowTrailing 4 quarters
$-480.0K
$71.7M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
MSGS
MSGS
REAX
REAX
Q4 25
$32.4M
Q3 25
$-85.0M
$8.8M
Q2 25
$49.7M
$41.0M
Q1 25
$6.3M
$15.9M
Q4 24
$61.8M
Q3 24
$-26.2M
$7.2M
Q2 24
$108.4M
Q1 24
$4.0M
$21.5M
Free Cash Flow
MSGS
MSGS
REAX
REAX
Q4 25
$31.6M
Q3 25
$-85.3M
$8.4M
Q2 25
$49.4M
$40.8M
Q1 25
$3.9M
$15.7M
Q4 24
$61.2M
Q3 24
$-26.5M
$6.8M
Q2 24
$108.0M
Q1 24
$3.9M
$21.4M
FCF Margin
MSGS
MSGS
REAX
REAX
Q4 25
7.8%
Q3 25
-216.3%
1.5%
Q2 25
24.2%
7.5%
Q1 25
0.9%
4.4%
Q4 24
17.1%
Q3 24
-49.7%
1.8%
Q2 24
47.5%
Q1 24
0.9%
10.7%
Capex Intensity
MSGS
MSGS
REAX
REAX
Q4 25
0.2%
Q3 25
0.9%
0.1%
Q2 25
0.2%
0.0%
Q1 25
0.6%
0.1%
Q4 24
0.1%
Q3 24
0.7%
0.1%
Q2 24
0.2%
Q1 24
0.0%
0.0%
Cash Conversion
MSGS
MSGS
REAX
REAX
Q4 25
3.94×
Q3 25
Q2 25
27.13×
Q1 25
Q4 24
55.61×
Q3 24
Q2 24
4.25×
Q1 24
0.11×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

MSGS
MSGS

Event Related$167.2M41%
Media Rights$122.3M30%
Sponsorship Signage And Suite Licenses$98.5M24%
League Distribution$15.4M4%

REAX
REAX

Segment breakdown not available.

Related Comparisons